Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
25.50    0.70 (2.82%)
Bid:
24.60
Ask:
25.80
Spread: 1.20 (4.878%)
Market Cap: £109.78m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

AGM Statement

15 May 2006 10:26

Immediate Release: 15 May 2006 International Brand Licensing plc ("IBL" or the "Company") AGM Statement At today's AGM, Chairman Adam Reynolds commented:"In my statement of 19th April 2006, I was pleased to report a substantialturnaround in the Company's fortunes by producing a full year profit for thefirst time in the Company's history.I am now delighted to announce to you that the current year has startedextremely well with the first four month's sales being around 25% higher thanthe corresponding period last year, which in itself was a record year. Inaddition, the Board is continuing to drive down fixed costs and is activelylooking at ways of increasing its gross margins through both manufacturing anddistribution efficiencies.It is both reassuring and rewarding that sales of the official England Admiralreplica kit are still outperforming all our expectations and that the Companyis further benefiting from its focus on cost savings since the Board wasrestructured last year.Last week, the Company announced the sale of its Admiral trademarks for theGreece and Cyprus territories for a cash consideration of ‚£775,000, reflectingthe increasing value of the Admiral brand globally. Whilst expanding thegeographical reach of the Admiral brand remains at the core of the Company'sstrategy, our over-riding aim is to maximise shareholder value which we firmlybelieve this transaction achieved.We are currently in discussion with several potential partners regarding thesigning of new long term license agreements in regions where we are currentlynot represented. We are confident that the number of territories in which theAdmiral brand is distributed, currently 22, can be substantially increased inthe medium to long term, ensuring continued strong growth in the business goingforward.Your Board is delighted with the progress the Company has made during the yearto date and we remain confident that we will continue to improve shareholdervalue throughout the year ahead."For Further information:Adam Reynolds/Paul FoulgerInternational Brand Licensing020 7823 1733ENDINTERNATIONAL BRAND LICENSING PLC
Date   Source Headline
19th Sep 20187:00 amRNSHalf-year Report
17th Sep 201812:21 pmRNSNotice of Results
31st Aug 20182:00 pmRNSUpdate regarding proposed IPO of Renalytix AI
16th Aug 20187:00 amRNSHolding(s) in Company
9th Aug 20187:14 amRNSTrading update
9th Aug 20187:00 amRNSDiaSpect Tm McKesson US distribution agreement
8th Aug 20184:09 pmRNSHolding(s) in Company
24th Jul 20188:45 amRNSUS distribution agreement for diabetes assay kit
19th Jul 20187:00 amRNSManufacturing partnership with Oragenics, Inc.
4th Jul 20183:15 pmRNSExploring funding options for Renalytix AI
7th Jun 20182:30 pmRNSHolding(s) in Company
1st Jun 201810:00 amRNSUpdate regarding Renalytix AI PLC
31st May 20187:00 amRNSLicence and collaboration agreement signed
8th May 20183:10 pmRNSResult of AGM
18th Apr 201810:36 amRNSPosting of AR and Accounts & Notice of AGM
9th Apr 20188:25 amRNSUS FDA approval for Diaspect Tm
21st Mar 20182:18 pmRNSHolding(s) in Company
14th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
11th Jan 20187:00 amRNSTrading update
29th Dec 20177:00 amRNSTotal Voting Rights
21st Dec 20177:00 amRNSShare cancellation
1st Dec 20177:00 amRNSTotal Voting Rights
7th Nov 20173:07 pmRNSHolding(s) in Company
2nd Nov 20179:18 amRNSConfirmation of share cancellation
1st Nov 20177:00 amRNSTotal Voting Rights
27th Oct 20175:05 pmRNSHolding(s) in Company
3rd Oct 20173:44 pmRNSCancellation of escrow shares PDMR dealing/buyback
21st Sep 201710:16 amRNSHolding(s) in Company
11th Sep 20177:00 amRNSHalf-year Report
6th Sep 20171:41 pmRNSReduction of capital
31st Aug 20177:00 amRNSNotice of Results
10th Aug 20177:00 amRNSHolding(s) in Company
7th Aug 20179:45 amRNSHolding(s) in Company
27th Jul 201711:18 amRNSResult of General Meeting
19th Jul 20178:54 amRNSHolding(s) in Company
6th Jul 20177:00 amRNSTrading update
26th Jun 20177:00 amRNSNotice of GM
26th Jun 20177:00 amRNSCancellation of share options
10th May 201711:45 amRNSResult of AGM
10th May 20177:00 amRNSTrading Update & Structure Update
18th Apr 201712:00 pmRNSAnnual Financial Report
4th Apr 201710:55 amRNSHolding(s) in Company
21st Mar 20171:47 pmRNSDirector/PDMR Shareholding
21st Mar 201712:04 pmRNSHolding(s) in Company
20th Mar 20177:00 amRNSUpdate
20th Mar 20177:00 amRNSFinal Results
2nd Mar 20177:00 amRNSNotice of Results
22nd Feb 20177:00 amRNSChange of Nominated Adviser and Broker
9th Jan 20177:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.